Track the Senzime AB (publ.) stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Senzime AB (publ.) has logged 5 public disclosures. Market capitalisation: €581.7m. The latest transaction was reported on 9 December 2025 (Purchase). Among the most active insiders: Lars Axelsson. The full history is openly available.
5
Insider Decl.
n/a
Thresholds
€104,477
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Senzime AB (publ.) Strong Buy (bullish), based on 1 analysts. Average price target: SEK 10.50.
28Σ signal
Buys €104,477n/a Sells
Fundamental score
Ranked 26,837 of 29,062 companies
19.2
score / 100
Value
9
Quality
29
FCF yld-22%
Earn yld-24%
EV/EBITDA·
ROE-35%
Gross mgn33%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.